Difference between revisions of "Male Feminising Syndrome"
Jump to navigation
Jump to search
(New page: {{toplink |backcolour = FAFAD2 |linkpage =Endocrine System - Pathology |linktext =Endocrine System |maplink = Endocrine System (Content Map) - Pathology |pagetype =Pathology |sublink1=Sex ...) |
|||
Line 1: | Line 1: | ||
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation. | Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation. | ||
Line 15: | Line 6: | ||
*Anti-seborrhoeic shampoo. | *Anti-seborrhoeic shampoo. | ||
*Methyltestosterone. | *Methyltestosterone. | ||
+ | |||
+ | |||
+ | [[Category:Endocrine System - Pathology]] | ||
+ | [[Category:Reproductive System - Pathology]] |
Revision as of 14:19, 21 February 2011
Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation.
Treatment:
- Castration.
- Anti-seborrhoeic shampoo.
- Methyltestosterone.